| Patient | Marcus Aurelius |
|---|---|
| Date of birth | 0121-04-25 |
| Identifiers | MRN HR-AC004-SYN-TD; SSN (made up) 000-04-1213 |
| Document date | 0174-06-16 |
| Author | Octavia Ashworth-Nnamdi, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Five-week review, four weeks on omeprazole: reflux, biopsy result, sleep, and the remedy. [S]
Mr. Aurelius returns four weeks after his endoscopy. The burning after meals eased within a week of starting omeprazole and has now gone, and he no longer wakes with a sour taste. He takes the capsule before breakfast each day, eats his main meal early in the evening and has raised the head of his bed. His appetite has come back and he has gained weight. He has had two CBT-I sessions, the first a fortnight ago, and keeps a sleep diary: he now goes to bed only when sleepy and gets up at a fixed hour. Ten days ago he decided, on his own, to take the herbal paste only on alternate nights. For the first three or four nights without it he felt restless and slept badly; that has settled, and he has no craving for it. He has not increased the amount on the nights he takes it. His stools are regular with polyethylene glycol two or three times a week. [S]
| Element | Detail |
|---|---|
| Reflux | Gone on omeprazole; no night waking from it |
| Sleep | Two CBT-I sessions; Insomnia Severity Index 12 |
| Remedy | Alternate nights for ten days, by his choice; brief restlessness that settled; no craving |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Appetite better; weight up; less tired |
| Gastrointestinal | Negative | No heartburn, pain after meals, difficulty swallowing, vomiting or black stools |
| Cardiovascular | Negative | No chest pain |
| Psychiatric | Positive | Sleep improving but still short; mood better; no thoughts of self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Opium-containing compounded herbal paste (an electuary of honey, many herbs and poppy, from an overseas supplier; not prescribed and not regulated, so its morphine content is unknown), about a pea-sized amount (roughly 0.5 g) by mouth at bedtime most nights for about six years, and now and then in the morning before a long day | About 0.5 g at bedtime most nights; occasionally a second amount in the morning | Oral route | 0168-05-01 to 0174-06-06 | completed | S |
| Calcium carbonate 500 mg chewable tablet, one or two tablets as needed for heartburn, no more than six a day, until the endoscopy | One or two tablets as needed, at least four hours apart; no more than six a day | Oral route | 0174-05-12 to 0174-05-19 | completed | S |
| Polyethylene glycol 3350 powder, 17 g dissolved in a glass of water by mouth once daily as needed for constipation | 17 g once daily as needed | Oral route | 0174-05-12 | active | S |
| Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeated in 2 to 3 minutes in the other nostril if there is no response; call 911 | One spray for suspected overdose; repeat every 2 to 3 minutes if needed | Nasal route | 0174-05-12 | active | S |
| Omeprazole 20 mg delayed-release capsule, one capsule by mouth 30 to 60 minutes before breakfast for eight weeks, for erosive esophagitis | One capsule each morning before breakfast for eight weeks | Oral route | 0174-05-19 to 0174-07-14 | completed | S |
| Opium-containing compounded herbal paste (unregulated, strength unknown), about 0.5 g by mouth at bedtime on alternate nights, a reduction he chose and made himself | About 0.5 g at bedtime every other night | Oral route | 0174-06-06 to 0174-07-28 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 0174-06-16 | Body height | 172 | cm | S |
| 0174-06-16 | Body weight | 64 | kg | S |
| 0174-06-16 | Body mass index (BMI) [Ratio] | 21.6 | kg/m2 | S |
| 0174-06-16 | Systolic blood pressure | 120 | mm[Hg] | S |
| 0174-06-16 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 0174-06-16 | Heart rate | 72 | /min | S |
| 0174-06-16 | Respiratory rate | 14 | /min | S |
| 0174-06-16 | Body temperature | 36.6 | Cel | S |
| 0174-06-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 0174-06-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S |
Vital signs recorded on 0174-06-16; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 64.0 kg; pulse 72, blood pressure 120/76 |
| Abdomen | Soft and non-tender |
| Neurological | No tremor, sweating, yawning or dilated pupils |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Burning and pressing pain in the upper abdomen and lower chest after meals, for more than a year and worse over three months, with poor appetite, waking at night with pain and a sour taste, and a 3 kg weight loss; not brought on by exertion; normal ECG; cardiac and peptic causes to be excluded | resolved | confirmed | R10.13 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its pattern echoes the stomach and chest complaints and the pain with food that Dio describes (D). |
| Gastroesophageal reflux disease with erosive esophagitis, Los Angeles grade B, and a 2 cm sliding hiatal hernia; Helicobacter pylori negative on biopsy; coronary disease excluded by CT coronary angiography; synthetic modern diagnosis for his documented stomach and chest complaints | active | confirmed | K21.00 | S — Synthetic modern diagnosis; the cause of his real complaints is unknown and no historical diagnosis is made. |
| Daily use of an unregulated opium-containing herbal remedy for about six years, for stomach pain and sleep; opioid use disorder criteria not met (one DSM-5-TR criterion, restlessness and poor sleep when he stopped it); expected physiological dependence; constipation and possibly slowed gastric emptying from the opioid | active | confirmed | F11.90 | S — Synthetic modern finding anchored to the theriac he took (D); no opioid use disorder or addiction is attributed to him (the claim is disputed, R). |
| Chronic insomnia disorder for more than a year, with waking from night pain and trouble returning to sleep; Insomnia Severity Index 17 (moderate) | active | confirmed | G47.00 | S — Synthetic modern finding anchored to Galen's account of his sleeplessness without the poppy juice (D, possible). |
| Sustained strain of command: leads a large organization through a long field assignment far from home, with long days and little rest | active | confirmed | Z56.6 | S — Synthetic work strain anchored to his documented years on campaign (D). |
| Constipation from the opioid in his remedy: hard stools every two or three days | active | confirmed | K59.03 | S — Synthetic finding at intake. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Reflux symptoms: heartburn, chest pain after meals, regurgitation, night waking | Every visit | Completed today | Resolved within a week of omeprazole |
| Examination | Alarm features: difficulty or pain swallowing, bleeding, vomiting, weight loss, anemia | Every visit | Completed today | None; weight up to 64.0 kg |
| Laboratory | Helicobacter pylori histology | At endoscopy; result at the next visit | Completed today | Negative; no gastritis |
| Medication safety | Proton pump inhibitor: dose, timing before breakfast, and adherence | Eight weeks for erosive esophagitis, then the lowest effective dose or on demand | Completed today | Taken before breakfast daily; four more weeks, then on demand |
| Self-management | Meal timing, head-of-bed elevation, alcohol at night | Every visit | Completed today | Main meal early; head of bed raised; wine rarely at night |
| Medication safety | Opium-containing remedy: amount, pattern, benefits and harms, his own goals | Every visit | Completed today | Alternate nights for ten days, by his choice; same amount when taken |
| Medication safety | Reassessment after a change in opioid use | Within one to four weeks of a change | Completed today | Reviewed today, ten days after his change; benefits kept, brief withdrawal settled |
| Medication safety | Naloxone at home and no alcohol or sedatives with the remedy | Every visit | Completed today | At the bedside; no alcohol on remedy nights |
| Medication safety | DSM-5-TR opioid use disorder criteria | At intake and when the pattern changes | Completed today | Mild withdrawal on the first nights off, now settled; no other criterion |
| Survey | Suicide risk and safety review | Every visit | Completed today | No thoughts of self-harm |
| Survey | PHQ-9 and GAD-7 | At intake, at follow-up and at the end of the episode | Completed today | PHQ-9 5 |
| Survey | Insomnia Severity Index | At intake and at each review | Completed today | 12, down from 17 |
| Self-management | Cognitive behavioral therapy for insomnia (six sessions) with sleep diary | Weekly or every two weeks for six sessions | Completed today | Two sessions done; sleep diary kept |
| Self-management | Constipation on the opioid | Every visit | Completed today | Regular with polyethylene glycol two or three times a week |
| Laboratory | Cardiovascular risk and statin decision | Every four to six years by the PREVENT equations | Not indicated | Calcium score 0 with LDL 133 mg/dL and lipoprotein(a) 38 nmol/L: low risk; no statin; recalculate in four to six years |
Goal progress:
Guideline basis: ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease (2022); ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024); CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline (2021); Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016); Depression and Suicide Risk in Adults: Screening (2023); CMID: Clinical Monitoring Intelligence Database, hyperlipidemia and ischemic heart disease monographs (2026)
Follow-up: Preventive visit as booked; fifteen-week review after the omeprazole course. Return for heartburn that comes back most days, difficulty swallowing, or any chest pain on exertion. Next scheduled visit 0174-07-28: periodic adult preventive visit. [S]